141 related articles for article (PubMed ID: 10202614)
1. The impact of (1:1) cyclosporine A conversion to its microemulsion formulation on the kidney function of patients with cardiac allografts.
Khajehdehi P; Yip D; Bastani B
Clin Transplant; 1999 Apr; 13(2):176-80. PubMed ID: 10202614
[TBL] [Abstract][Full Text] [Related]
2. Equivalence of cyclosporine blood level assays in patients receiving cyclosporine microemulsion or cyclosporine. The Sandoz Neoral Study Group N103.
Pescovitz MD; Wong RL; Choc MG; Chang CT
Clin Transplant; 1997 Oct; 11(5 Pt 1):442-5. PubMed ID: 9361938
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function.
Qazi YA; Forrest A; Tornatore K; Venuto RC
Clin Transplant; 2006; 20(3):313-7. PubMed ID: 16824147
[TBL] [Abstract][Full Text] [Related]
4. Reversal of cyclosporine malabsorption in diabetic recipients of simultaneous pancreas and kidney transplant using a microemulsion formulation.
Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
Transplantation; 1996 Jun; 61(12):1699-704. PubMed ID: 8685946
[TBL] [Abstract][Full Text] [Related]
5. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
White M; Pelletier GB; Tan A; Jesina C; Carrier M
J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
[TBL] [Abstract][Full Text] [Related]
7. [Conversion from +Sandimmune to Neoral in kidney transplant recipients treated with cyclosporine and ketoconazole].
Videla C; Vega J; Borja H; Gatica A; Clavero R; Aldunate T
Rev Med Chil; 1997 Apr; 125(4):438-45. PubMed ID: 9460285
[TBL] [Abstract][Full Text] [Related]
8. Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year.
Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Budde K; Waiser J; Luft FC
Nephrol Dial Transplant; 1996 Jan; 11(1):165-72. PubMed ID: 8649628
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.
Frei UA; Neumayer HH; Buchholz B; Niese D; Mueller EA
Transplantation; 1998 Jun; 65(11):1455-60. PubMed ID: 9645802
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
Noble S; Markham A
Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033
[TBL] [Abstract][Full Text] [Related]
11. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center.
Tinawi M; Miller L; Bastani B
Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686
[TBL] [Abstract][Full Text] [Related]
12. Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
Zachariae H; Abrams B; Bleehen SS; Bräutigam M; Burrows D; Ettelt MJ; Fry L; Happle R; Haustein UF; Ganslandt J; Jung EG; Knop J; Kühne KH; Mellein B; Mørk NJ; Rogers S; Schmidt AG; Schopf RE; Sumner M; Taube KM; Weidinger G; Wurdel C; Zahn E
Dermatology; 1998; 196(2):231-6. PubMed ID: 9568413
[TBL] [Abstract][Full Text] [Related]
13. Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics.
Anderson IF; Helve T; Hannonen P; Leirisalo-Repo M; Gilboe IM; Nissilä M; Keystone EC; Kraag GR; Bjørneboe O; Chalmers A; Dovland H; Mueller E; Richard F; Whatmough I; Schmidt AG; Kovarik JM
J Rheumatol; 1999 Mar; 26(3):556-62. PubMed ID: 10090162
[TBL] [Abstract][Full Text] [Related]
14. Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.
Neumayer HH; Budde K; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
Clin Nephrol; 1996 May; 45(5):326-31. PubMed ID: 8738665
[TBL] [Abstract][Full Text] [Related]
15. Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.
Wahlberg J; Wilczek HE; Fauchald P; Nordal KP; Heaf JG; Olgaard K; Hansen JM; Lokkegaard H; Mueller EA; Kovarik JM
Transplantation; 1995 Oct; 60(7):648-52. PubMed ID: 7570970
[TBL] [Abstract][Full Text] [Related]
16. Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune Neoral.
Chu SH; Pang ST; Chiang YJ; Chuang CK; Chen HW; Chen CS; Chou CC; Huang CC
Transplant Proc; 1998 Nov; 30(7):3521-3. PubMed ID: 9838543
[No Abstract] [Full Text] [Related]
17. Pharmacokinetic effects of conversion to a new formulation of cyclosporin A in rheumatoid arthritis patients.
Marchesoni A; Fantini F; Battafarano N; Zeni S; Ruiu G; Padula A; Taglione E; Pasero G; Leoni L
Rheumatol Int; 1998; 17(5):197-202. PubMed ID: 9542781
[TBL] [Abstract][Full Text] [Related]
18. Conversion and pharmacokinetic studies of a microemulsion formulation of cyclosporine in pediatric liver transplant patients.
D'Agostino D; Gimenez M; Yamaguchi B; Glancszpigel R; Vinuesa F; Gamba M; Ciardullo M; de Santibaes E
Transplantation; 1996 Oct; 62(8):1068-71. PubMed ID: 8900303
[TBL] [Abstract][Full Text] [Related]
19. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral.
Ritschel WA
Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
Otto MG; Mayer AD; Clavien PA; Cavallari A; Gunawardena KA; Mueller EA
Transplantation; 1998 Dec; 66(12):1632-40. PubMed ID: 9884251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
